ArticleFrontiers in oncology2026

Clinical outcomes and survival in patients with NSCLC and EGFR exon 20 mutations: evidence from real-world clinical practice in a retrospective study in Galicia.

Begoña Campos Balea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.